Gerresheimer AG (GXI.DE)
XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
As of 04:37PM CEST. Market open.
| Previous Close | 102.00 |
| Open | 101.70 |
| Bid | 102.30 x 21100 |
| Ask | 102.50 x 8200 |
| Day's Range | 101.60 - 102.90 |
| 52 Week Range | 81.35 - 122.90 |
| Volume | |
| Avg. Volume | 113,360 |
| Market Cap | 3.537B |
| Beta (5Y Monthly) | 0.90 |
| PE Ratio (TTM) | 29.26 |
| EPS (TTM) | 3.50 |
| Earnings Date | Jul 11, 2024 |
| Forward Dividend & Yield | 1.25 (1.23%) |
| Ex-Dividend Date | Jun 06, 2024 |
| 1y Target Est | 89.60 |
Simply Wall St.What Does Gerresheimer AG's (ETR:GXI) Share Price Indicate?
Gerresheimer AG ( ETR:GXI ), might not be a large cap stock, but it saw a decent share price growth of 17% on the XTRA...
CNW GroupGerresheimer partners with RxCap to offer connected adherence solutions
Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, has entered into a partnership with the US digital health company RxCap and acquired a minority stake. Under the terms of the agreement, Gerresheimer's subsidiary Centor will receive the exclusive distribution rights for pharmacies in the U.S. for adherence solutions by RxCap, consisting of connected prescription vial closure devices and complementary cloud-based softwa
- Simply Wall St.
Earnings Update: Gerresheimer AG (ETR:GXI) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts
Shareholders might have noticed that Gerresheimer AG ( ETR:GXI ) filed its quarterly result this time last week. The...
© 2024 Yahoo. All rights reserved.